Skip to main content
Log in

Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

The reactivity with monoclonal antibodies (MoAbs) specific for myelomonocytic cells and the expression of a particular esterase isoenzyme were analyzed in 159 cases of acute myeloid leukemias. The incidence of positivity of 16 MoAbs (MCS-2, MCS-1, OKM1, My-1, Leu-M1, Leu-M3, CA-2-38, MY4, MY7, MY8, MY9, VIM-D2, VIM-D5, Mo1, Mo2, 63D3) was studied using the indirect immunofluorescence technique. A carboxylic esterase isoenzyme which can be inhibited completely and selectively by sodium fluoride (NaF) was demonstrated by isoelectric focusing on horizontal polyacrylamide gels. This NaF-sensitive isoenzyme indicated the monocytic origin of the blast cells as it is specific for this cell lineage. Prior to the immunological-isoenzymatic analysis all cases were categorized into two subtypes according to morphological criteria of the FAB classification system: 147 cases of AML (FAB M1-3) and 12 cases of AMMoL/AMoL (FAB M4/5). However, 15 out of 147 cases of AML expressed the NaF-sensitive isoenzyme and were therefore assigned to the group AMMoL/AMoL. Likewise, 1 case, diagnosed morphologically as AMMoL, was negative for this marker isoenzyme and was assigned to the other leukemia subtype. The incidence of reactivity varied widely for the MoAbs tested regarding the overall results on all cases and the positivity on cases of either AML or AMMoL/AMoL. The MoAbs were grouped into four classes depending on the pattern of reactivity with myeloblastic or monoblastic or both subtypes of acute myeloid leukemia. The MoAbs MCS-2, MY7, Leu-M1, and MY9 detected the vast majority of cases with either myelocytic or monocytic involvement (group-I: “pan-myelomonocytic” reactivity). The MoAbs MCS-1, OKM1, VIM-D5, and Mo1 showed a predominance in their staining pattern for monocytic variants, but were also positive on a substantial percentage of nonmonocytic cases (group-II: predominantly reactive with monocytic, but also myelocytic cases). The MoAbs Leu-M3, MY4, VIM-D2, Mo2, and MY8 reacted with the large majority of AMMoL/AMoL cases and with a small number of AML cases (group-III: monocyte-“specific” reactivity). The MoAbs of group-I are useful in differentiating acute lymphoid from acute myeloid leukemias. The MoAbs of group-III, and to a lower extent those of group-II, will be of considerable value in the subtyping of acute myeloid leukemias. The results show that (1) accuracy of leukemia classification might not always be achieved by morphology alone, but that immunological and biochemical aspects should be included as well, and (2) several MoAbs are very useful tools for classification and subtyping of acute myeloid leukemias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bennett JM, Catovsky D, Daniel M-Th, Flandrin G, Galton AG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33:451

    CAS  PubMed  Google Scholar 

  2. Bernard A, Boumsell L, Dausset J, Milstein C, Schlossman SF (1984) Leucocyte typing. Springer-Verlag, Berlin

    Google Scholar 

  3. Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1980) A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol 124:1943

    Google Scholar 

  4. Civin CI, Mirro J, Banquerigo ML (1981) My-1, a new myeloid-specific antigen identified by a mouse monoclonal antibody. Blood 57:842

    Google Scholar 

  5. Dimitriu-Bona A, Burmester GR, Waters SJ, Winchester RJ (1983) Human mononuclear phagocyte differentiation antigens. I. Patterns of antigen expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. J Immunol 130:145

    Google Scholar 

  6. Drexler HG, Gaedicke G (1983) Isoenzyme studies in human leukemia. II. Carboxylic esterase (E.C.3.1.1.1). Leuk Res 7:599

    Google Scholar 

  7. Drexler HG, Gaedicke G, Minowada J (1984) Enzyme markers in acute leukemias: Advances during the last decade. J Natl Cancer Inst 72:1283

    Google Scholar 

  8. Drexler HG, Sagawa K, Menon M, Minowada J (1985a) “Pan-myeloid” reagent: The monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping. Gann 76:235

    Google Scholar 

  9. Drexler HG, Gaedicke G, Minowada J (1985b) Isoenzyme studies in human leukemia-lymphoma cell lines. I. Carboxylic esterase. Leuk Res 9:209

    Google Scholar 

  10. Flandrin G, Daniel M-Th (1981) Cytochemistry in the classification of leukemias. In: Catovsky D (ed) The leukemic cell. Churchill-Livingstone, Edinburgh, p 29

    Google Scholar 

  11. Greaves MF, Grossi CE, Habeshaw JA, Lombardi L, Rilke F, Stansfeld AG (1981) Lymphocytes. In: Zucker-Franklin D, Greaves MF, Grossi CE, Marmont AM (eds) Atlas of blood cells — function and pathology. Lea & Febiger, Philadelphia, p 409

    Google Scholar 

  12. Griffin JD, Schlossman SF (1984a) Expression of myeloid differentiation antigens in acute myeloblastic leukemia. In: Bernard A, Boumsell L, Dausset J, Milstein C, Schlossman SF (eds) Leucocyte typing. Springer-Verlag, Berlin, p 404

    Google Scholar 

  13. Griffin JD, Ritz J, Nadler LM, Schlossman SF (1981) Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 68:932

    Google Scholar 

  14. Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF (1984b) A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk Res 8:521

    Google Scholar 

  15. Hanjan SNS, Kearney JF, Cooper MD (1982) A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. Clin Immunol Immunopathol 23:172

    Google Scholar 

  16. Hoffbrand AV, Janossy G (1981) Enzyme and membrane markers in leukaemia: Recent developments. J Clin Pathol 34:254

    Google Scholar 

  17. Knapp W, Bettelheim P, Majdic O, Liszka K, Schmidmeier W, Lutz D (1984a) Diagnostic value of monoclonal antibodies to leucocyte differentiation antigens in lymphoid and non-lymphoid leukemias. In: Bernard A, Boumsell L, Dausset J, Milstein C, Schlossman SF (eds) Leucocyte typing. Springer-Verlag, Berlin, p 564

    Google Scholar 

  18. Knapp W, Majdic O, Bettelheim P, Liszka K, Aberer W, Stingl G (1984b) Typing of leukemic cells with monoclonal antibodies. Ann NY Acad Sci 420:251

    Google Scholar 

  19. Linch DC, Allen C, Beverley PCL, Bynoe AG, Scott CS, Hogg N (1984) Monoclonal antibodies differentiating between monocytic and nonmonocytic variants of AML. Blood 63:566

    Google Scholar 

  20. Majdic O, Liszka K, Lutz D, Knapp W (1981) Myeloid differentiation antigen defined by a monoclonal antibody. Blood 58:1127

    Google Scholar 

  21. Majdic O, Bettelheim P, Stockinger H, Aberer W, Liszka K, Lutz D, Knapp W (1984) M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells. Int J Cancer 33:617

    Google Scholar 

  22. Minowada J (1985) Immunology of leukemia and lymphoma. In: Wiernik P (ed) Contemporary issues in clinical oncology, vol 4. Leukemias and lymphomas. Churchill-Livingstone, Edinburgh, p 183

    Google Scholar 

  23. Minowada J, Sagawa K, Trowbridge IS, Kung PC, Goldstein G (1982) Marker profiles of 55 human leukemia-lymphoma cell lines. In: Rosenberg SA, Kaplan HS (eds) Malignant lymphomas. Etiology, immunology, pathology, treatment. Academic Press, New York, p 53

    Google Scholar 

  24. Radzun HJ, Parwaresch M, Wittke JW (1981) Polymorphism and antigenic specificity of monocytic acid esterase (E.C.3.1.1.6). Cell Immunol 63:400

    Google Scholar 

  25. Reijden HJ van der, Rhenen DJ van, Lansdorp PM, Veer MB van't, Langenhuijsen MMAC, Engelfriet CP, Borne AEGKr von dem (1983) A comparison of surface marker analysis and FAB classification in acute myeloid leukemia. Blood 61:443

    Google Scholar 

  26. Scott CS, Linch DC, Bynoe AG, Allen C, Hogg N, Ainley MJ, Hough D, Roberts BE (1984) Electrophoretic and cytochemical characterization of alpha-naphthylacetate esterase in acute myeloid leukemia: Relationships with membrane receptor and monocyte-specific antigen expression. Blood 63:579

    Google Scholar 

  27. Todd III RF, Nadler LM, Schlossman SF (1981) Antigens on human monocytes identified by monoclonal antibodies. J Immunol 127:1435

    Google Scholar 

  28. Todd III RF, Bhan AK, Kabawat SE, Schlossman SF (1984) Human myelomonocytic differentiation antigens defined by monoclonal antibodies. In: Bernard A, Boumsell L, Dausset J, Milstein C, Schlossman SF (eds) Leucocyte typing. Springer-Verlag, Berlin, p 424

    Google Scholar 

  29. Tatsumi E, Sagawa K, Mirro J, Civin CI, Preisler HD, Henderson ES, Minowada J (1981) Immunologic membrane phenotypes in human myeloid leukemia by monoclonal antibodies. Proc Am Assoc Cancer Res 22:181

    Google Scholar 

  30. Ugolini V, Nunez G, Smith RG, Stastny P, Capra JD (1980) Initial characterization of monoclonal antibodies against human monocytes. Proc Natl Acad Sci USA 77:6764

    Google Scholar 

  31. Zittoun R, Cadiou M, Bayle C, Suciu S, Solbu G, Hayat M (1984) Prognostic value of cytologic parameters in acute myelogenous leukemia. Cancer 53:1526

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drexler, H.G., Menon, M., Gaedicke, G. et al. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis. Cancer Immunol Immunother 21, 188–192 (1986). https://doi.org/10.1007/BF00199360

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199360

Keywords

Navigation